Informational only — Not medical advice. Always consult a licensed healthcare provider.

Community data Updated 2 months ago

Save on this medicine

Other brands with the same active ingredient

These brands contain the same active ingredient (Sotagliflozin). Same strength and form. Confirm the switch with your doctor or pharmacist.

Indications & Uses

Elpida 200 is indicated for:

Dosage Reference

Reference Information Only

Dosages shown are general references from official sources. Always consult your doctor or pharmacist for personalized dosing.

Adults:

Sotagliflozin is administered by the oral route. The recommended dose is 200 mg sotagliflozin once daily before the first meal of the day. After at least three months, if additional glycaemic control is needed, in patients tolerating sotagliflozin 200 mg, the dose may be increased to 400 mg once daily.

Side Effects

Hypotension, renal impairment, hepatic impairment, genital mycotic infections, urinary tract infections, nausea, vomiting, or abdominal pain, excessive thirst, constantly feeling tired, high levels of ketones in urine tests or beta-hydroxybutyrate (BHB) in blood tests, difficulty breathing/rapid, deep breathing, difficulty paying attention, or confusion, rapid weight loss.

Cautions & Contraindications

Warnings & Precautions

Hypotension: Before initiating Elpida, volume status should be assessed and correction on hypovolemia should be made in the elderly, in patients with renal impairment, in patients with low systolic blood pressure and in patients on diuretics since Elpida causes intravascular volume contraction.Impairment in Renal Function: Renal function should be evaluated prior to initiating Elpida and periodically. Initiation of Elpida is not recommended when eGFR is less than 60 ml/min/1.73 m2 and should be discontinued if eGFR is persistently less than 45 mL/min/1.73 m2Hepatic impairment: Elpida is not recommended in patients with moderate and severe hepatic impairment, as Elpida exposure is increased in these patients.Genital mycotic infections: Monitoring and treatment should be done as appropriate. Urinary tract infections: Temporary interruption of Elpida should be considered when treating pyelonephritis and urosepsis.

Contraindications

Hypersensitivity to the active substance or to any of the excipients.

Drug Interactions

Open checker →
Last updated: 15 Aug 2026